The DOI matches its Crossref record.
Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HPV-16 E5 can self-associate both in vitro and in vivo and form oligomers by hydrophobic interactions [24,25,26]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 51
- Adam, 2000, A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems, Virology, 272, 315, 10.1006/viro.2000.0376 · DOI
- Adduci, 1999, The transmembrane domain of the E5 oncoprotein contains functionally discrete helical faces, J. Biol. Chem., 274, 10249, 10.1074/jbc.274.15.10249 · DOI
- Andresson, 1995, Vacuolar H+-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein, J. Biol. Chem., 270, 6830, 10.1074/jbc.270.12.6830 · DOI
- Ashrafi, 2000, Binding of bovine papillomavirus type 4 E8 to ductin (16K proteolipid), down-regulation of gap junction intercellular communication and full cell transformation are independent events, J. Gen. Virol., 81, 689, 10.1099/0022-1317-81-3-689 · DOI
- Bryan, 1998, The intracellular expression pattern of the human papillomavirus type 11 E1Ê4 protein correlates with its ability to self associate, Virology, 241, 49, 10.1006/viro.1997.8965 · DOI
- Bubb, 1988, DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein, Virology, 163, 243, 10.1016/0042-6822(88)90259-0 · DOI
- Burkhardt, 1987, Genetic and biochemical definition of the bovine papillomavirus E5 transforming protein, EMBO J., 6, 2381, 10.1002/j.1460-2075.1987.tb02515.x · DOI
- Burkhardt, 1989, The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes, Virology, 170, 334, 10.1016/0042-6822(89)90391-7 · DOI
- Chen, 1996, Mutational analysis of human papillomavirus type 11 E5a oncoprotein, J. Virol., 70, 3502, 10.1128/jvi.70.6.3502-3508.1996 · DOI
- Chen, 1994, E5a gene of human papillomavirus type 11 is required for initiation but not for maintenance of transformation in NIH 3T3 cells, J. Gen. Virol., 75, 1953, 10.1099/0022-1317-75-8-1953 · DOI
- Conrad, 1993, The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein, J. Virol., 67, 6170, 10.1128/jvi.67.10.6170-6178.1993 · DOI
- Crusius, 1997, Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein, Oncogene, 15, 1437, 10.1038/sj.onc.1201312 · DOI · Paper page
- Crusius, 1998, The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT, Exp. Cell Res., 241, 76, 10.1006/excr.1998.4024 · DOI · Paper page
- Crusius, 1999, The human papillomavirus type 16 E5 protein modulates phospholipase C-γ-1 and phosphatidylinositol turnover in mouse fibroblasts, Oncogene, 18, 6714, 10.1038/sj.onc.1203075 · DOI
- Crusius, 2000, The human papillomavirus type 16 E5 protein modulates ERK1/2 and p38 MAP kinase activation by an EGFR-independent process in stressed human keratinocytes, Virus Genes, 20, 65, 10.1023/A:1008112207824 · DOI · Paper page
- Eilers, 2000, Internal packing of helical membrane proteins, Proc. Natl. Acad. Sci. USA, 97, 5796, 10.1073/pnas.97.11.5796 · DOI
- Finbow, 1997, The vacuolar H+-ATPase, Biochem. J., 324, 697, 10.1042/bj3240697 · DOI
- Goldstein, 1990, The E5 oncoprotein of bovine papillomavirus binds to a 16 kd protein, EMBO J., 9, 137, 10.1002/j.1460-2075.1990.tb08089.x · DOI
- Goldstein, 1994, The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the β-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation, J. Virol., 68, 4432, 10.1128/jvi.68.7.4432-4441.1994 · DOI
- Gray, 1984, Intrahelical hydrogen bonding of serine, threonine and cysteine residues within alpha-helices and its relevance to membrane-bound proteins, J. Mol. Biol., 175, 75, 10.1016/0022-2836(84)90446-7 · DOI
- Gromiha, 1999, A simple method for predicting transmembrane alpha helices with better accuracy, Prot. Eng., 12, 557, 10.1093/protein/12.7.557 · DOI
- Gu, 1995, Effect of human papillomavirus type 16 oncogenes on MAP kinase activity, J. Virol., 69, 8051, 10.1128/jvi.69.12.8051-8056.1995 · DOI · Paper page
- Hwang, 1995, The HPV16 E5 protein, Virology, 211, 227, 10.1006/viro.1995.1395 · DOI
- Kell, 1994, Detection of E5 oncoprotein in human papillomavirus type 16-positive cervical scrapes using antibodies raised to synthetic peptides, J. Gen. Virol., 75, 2451, 10.1099/0022-1317-75-9-2451 · DOI · Paper page
- Kulke, 1992, The central hydrophobic domain of the bovine papillomavirus E5 transforming protein can be functionally replaced by many hydrophobic amino acid sequences containing a glutamine, J. Virol., 66, 505, 10.1128/jvi.66.1.505-511.1992 · DOI
- Lai, 1998, Bovine papillomavirus E5 protein induces oligomerization and trans-phosphorylation of the platelet-derived growth factor β receptor, Proc. Natl. Acad. Sci. USA, 95, 15241, 10.1073/pnas.95.26.15241 · DOI
- Leechanachai, 1992, The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus, Oncogene, 7, 19
- Leptak, 1991, Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16, J. Virol., 65, 7078, 10.1128/jvi.65.12.7078-7083.1991 · DOI · Paper page
- Martin, 1989, The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors, Cell, 59, 21, 10.1016/0092-8674(89)90866-0 · DOI
- Mattoon, 2001, Identification of the transmembrane dimer interface of the bovine papillomavirus E5 protein, Oncogene, 20, 3824, 10.1038/sj.onc.1204523 · DOI
- Mayer, 1998, Temporal and spatial expression of the E5a protein during the differentiation-dependent life cycle of human papillomavirus type 31b, Virology, 248, 208, 10.1006/viro.1998.9262 · DOI
- Myers, 1993, Assembly of the peripheral domain of the bovine vacuolar H+-adenosine triphosphatase, J. Cell. Physiol., 156, 35, 10.1002/jcp.1041560106 · DOI
- Nelson, 1990, Disruption of genes encoding subunits of yeast vacuolar H+-ATPase causes conditional lethality, Proc. Natl. Acad. Sci. USA, 87, 3507, 10.1073/pnas.87.9.3503 · DOI
- Nilson, 1995, Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous β receptor for platelet-derived growth factor in mouse C127 cells, J. Virol., 69, 5869, 10.1128/jvi.69.9.5869-5874.1995 · DOI
- Oelze, 1995, Human papillomavirus type 16 E5 protein affects cell-cell communication in an epithelial cell line, J. Virol., 69, 4489, 10.1128/jvi.69.7.4489-4494.1995 · DOI
- Oetke, 2000, Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation, Arch. Virol., 145, 2183, 10.1007/s007050070048 · DOI
- Petti, 1991, Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein, EMBO J., 10, 845, 10.1002/j.1460-2075.1991.tb08017.x · DOI
- Pim, 1992, Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor, Oncogene, 7, 27
- Rodriguez, 2000, Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation, Oncogene, 19, 3727, 10.1038/sj.onc.1203718 · DOI
- Schapiro, 2000, Golgi alkalinization by the papillomavirus E5 oncoprotein, J. Cell. Biol., 148, 305, 10.1083/jcb.148.2.305 · DOI
- Schoonderwoert, 2000, Inhibition of the vacuolar H+-ATPase perturbs the transport, sorting, processing and release of regulated secretory proteins, J. Biochem., 267, 5646
- Smith, 1996, Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erbB2-receptor, Nat. Struct. Biol., 3, 252, 10.1038/nsb0396-252 · DOI
- Sparkowski, 1995, E5 oncoprotein retained in the endoplasmic reticulum/cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells, EMBO J., 14, 3055, 10.1002/j.1460-2075.1995.tb07308.x · DOI
- Sparkowski, 1996, E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation, J. Virol., 70, 2420, 10.1128/jvi.70.4.2420-2430.1996 · DOI
- Straight, 1995, The E5 oncoprotein of human papillomavirus type 15 inhibits the acidification of endosomes in human keratinocytes, J. Virol., 69, 3185, 10.1128/jvi.69.5.3185-3192.1995 · DOI
- Suprynowicz, 2000, E5 oncoprotein mutants activate phosphoinositide 3-kinase independently of platelet-derived growth factor receptor activation, J. Biol. Chem., 275, 5111, 10.1074/jbc.275.7.5111 · DOI
- Surti, 1998, Structural models of the bovine papillomavirus E5 protein, Proteins, 33, 601, 10.1002/(SICI)1097-0134(19981201)33:4<601::AID-PROT12>3.0.CO;2-I · DOI
- Ullman, 1994, Hypothetical structure of the membrane-associated E5 oncoprotein of human papillomavirus type 16, Biochem. Soc. Trans., 22, 439S, 10.1042/bst022439s · DOI
- Vali, 2001, Bovine papillomavirus oncoprotein E5 affects the arachidonic acid metabolism in cells, Int. J. Biochem. Cell Biol., 33, 227, 10.1016/S1357-2725(01)00015-2 · DOI
- Zhou, 2000, Interhelical hydrogen bonding drives strong interactions in membrane proteins, Nat. Struct. Biol., 7, 154, 10.1038/81919 · DOI
- Zhou, 2001, Polar residues drive association of polyleucine transmembrane helices, Proc. Natl. Acad. Sci. USA, 98, 2250, 10.1073/pnas.041593698 · DOI
Cited by
Basukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Metadata
- Authors
- Gieswein, C. E., Sharom, F. J., & Wildeman, A. G.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 2003-09
- Volume
- 313
- Issue
- 2
- Pages
- 415-426
- ISSN
- 0042-6822
- Cited by
- 27
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review